The interaction of Vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate

Citation
Lm. Mansky et al., The interaction of Vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate, J VIROLOGY, 74(15), 2000, pp. 7039-7047
Citations number
53
Categorie Soggetti
Microbiology
Journal title
JOURNAL OF VIROLOGY
ISSN journal
0022538X → ACNP
Volume
74
Issue
15
Year of publication
2000
Pages
7039 - 7047
Database
ISI
SICI code
0022-538X(200008)74:15<7039:TIOVWU>2.0.ZU;2-X
Abstract
The Vpr protein of human immunodeficiency virus type 1 (HIV-1) influences t he in vivo mutation rate of the virus. Since Vpr interacts with a cellular protein implicated in the DNA repair process, uracil DNA glycosylase (UNG), we have explored the contribution of this interaction to the mutation rate of HIV-1. Single-amino-acid variants of Vpr were characterized for their d ifferential UNG-binding properties and used to trans complement vpr null mu tant HIV-1. A striking correlation was established between the abilities of Vpr to interact with UNG and to influence the HIV-1 mutation rate. We demo nstrate that Vpr incorporation into virus particles is required to influenc e the in vivo mutation rate and to mediate virion packaging of the nuclear form of UNG. The recruitment of UNG into virions indicates a mechanism for how Vpr can influence reverse transcription accuracy. Our data suggest that distinct mechanisms evolved in primate and nonprimate lentiviruses to reco ncile uracil misincorporation into lentiviral DNA.